Director Kim R. Tsuchimoto of Monopar Therapeutics filed a Form 4 on November 4, 2026, disclosing a series of stock option exercises and open-market sales of common stock executed on November 2 and November 4, 2026, pursuant to a Rule 10b5-1 plan.
Director Yvonne Wassenaar filed a Form 4 with the SEC on November 4, 2026, reporting the conversion and sale of 721 shares of Rubrik, Inc. Class A Common Stock under a pre-established Rule 10b5-1 trading plan.
Director Raymond Anderson of Monopar Therapeutics (NASDAQ:MNPR) filed a Form 4 on November 4, 2026, disclosing option exercises and open-market share sales executed on November 2, 2026, pursuant to a Rule 10b5-1 plan.
Director Kira Scherer Wampler filed a Form 4 with the SEC on November 4, 2026, disclosing transactions in Doximity, Inc. (NYSE:DOCS) Class A Common Stock executed on November 2, 2026.
Southern Cross Acquisition II Sponsor Corp. and its sole shareholder Peizhong Yu filed Amendment No. 1 to a Schedule 13D with the SEC on November 4, 2026, disclosing beneficial ownership of 2,701,677 ordinary shares of Southern Cross Acquisition II Corp. following a partial forfeiture …
Southern Cross Acquisition II Sponsor Corp. and Peizhong Yu filed a Form 4 on November 4, 2026, disclosing the forfeiture of 324,123 ordinary shares of Southern Cross Acquisition II Corp. (NASDAQ:SCAT) on November 2, 2026, following the underwriter's partial exercise of its over-allotment option.
Natera, Inc. Chief Financial Officer Brophy Michael Burkes filed a Form 4 on November 4, 2026, disclosing three separate sales of Natera common stock totaling 795 shares on November 2 and 3, 2026, executed under Rule 10b5-1 plans.
Sergey Savchenko, Chief Financial Officer of Critical Metals Corp., filed a Form 4 on November 4, 2026, disclosing the sale of 66,667 ordinary shares on November 2, 2026.
Lauren Elaina Friedman Stat, a director of Palantir Technologies Inc., filed a Form 4 on November 4, 2026, disclosing a sale of 1,358 shares of Class A Common Stock on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.
Steven Leonard Chapman, CEO and President of Natera, Inc., filed a Form 4 on November 4, 2026, disclosing three sales of Natera common stock totaling 3,801 shares on November 2, 2026, conducted under Rule 10b5-1 plans.